You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Mass. Movers

Charles River’s 2013 forecast disappoints

Charles River’s business includes selling lab mice.

Globe file photo/2006

Charles River’s business includes selling lab mice.

Continue reading below

Charles River Laboratories International Inc., which provices drug-research services, gave 2013 earnings guidance that was below Wall Street’s expectations. In addition, the Wilmington company now expects its 2012 per-share earnings to come in between the low end and the midpoint of its previously estimated range of $2.68 to $2.73. The company expects sales to grow by 3 to 5 percent next year, and that non-GAAP earnings per share would be in the range of $2.80 to $2.90. The analyst consensus for 2013 is $3.02, RTTNews reported.

Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.